XGEVA 120 mg/1.7mL
denosumab · INJECTION · Amgen, Inc
No Recall History
Plain English
XGEVA is a injection containing denosumab at 120 mg/1.7mL, taken subcutaneous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- XGEVA
- Generic Name
- denosumab
- NDC Code (Product)
55513-730- Manufacturer
- Amgen, Inc
- Strength
- 120 mg/1.7mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125320
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 11/18/2010
Recall History
No Recall HistoryFrequently Asked Questions
What is XGEVA used for?
XGEVA contains denosumab. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is XGEVA a controlled substance?
XGEVA is not classified as a controlled substance by the DEA.
What is the generic name for XGEVA?
The generic name for XGEVA is denosumab. There are 12 other brand versions of denosumab.
What is the NDC code for XGEVA 120 mg/1.7mL?
The NDC (National Drug Code) for XGEVA 120 mg/1.7mL is 55513-730, listed by Amgen, Inc.